Wednesday, January 3, 2018

Swiss Giant Drug Company Novartis (NVS) With a Stock Market Cap of US$ 198 Bil Had 35% of Its 2016 Total Revenues Made To US Customers and 31% of Its 2016 Total Non-Current Assets Including Intangible Assets and Property, Plant and Equipment Assets, the Main Drivers of the Coveted US Deferred Income Tax Liabilities (DTLs), Located in the US

From NVS's US SEC Filings